Medical Condition News

RSS

Mount Sinai researchers use unbiased AI-based method to study the causes of cognitive impairment

Mount Sinai researchers have used novel artificial intelligence methods to examine structural and cellular features of human brain tissues to help determine the causes of Alzheimer's disease and other related disorders.

21 Sep 2022

Cutting-edge technology uses MRI to diagnose patients with heart failure in record time

Researchers at the University of East Anglia have developed cutting-edge technology to diagnose patients with heart failure in record time.

21 Sep 2022

Medical cannabis use reduces sleep disturbances caused by PTSD

Researchers assess the association between the use of medical cannabis and sleep.

21 Sep 2022

New genetically-targeted MND therapy could be a turning point for patient care

Scientists believe a new genetically-targeted therapy to treat motor neurone disease (MND) could be a turning point for patient care, after the results of a Phase 3 clinical trial showed significant physical benefits for patients after 12 months.

21 Sep 2022

Global burden of type 1 diabetes likely to double by 2040, study predicts

An estimated 8.4 million people were living with Type 1 Diabetes (T1D) across the globe in 2021, according to the results of a new modeling study published in The Lancet Diabetes & Endocrinology.

21 Sep 2022

Cardiovascular disease risk factors are largely the same for women and men, study shows

For women and men, the risk factors for cardiovascular disease are largely the same, an extensive global study involving University of Gothenburg shows.

21 Sep 2022

Artificial intelligence could help fast-track dementia diagnosis

Different forms of dementia could be spotted sooner and more easily by analyzing recordings of patients' electrical brain activity using artificial intelligence (AI), according to new research.

21 Sep 2022

Better physical fitness reduces frailty risk in patients with chronic lymphocytic leukemia

Increased levels of exercise could help reduce frailty in patients with the most common form of leukemia, chronic lymphocytic (CLL), according to new research from the University of Surrey.

21 Sep 2022

New guideline for the evaluation and testing of patients with penicillin allergies

A new guideline published in Clinical & Experimental Allergy will help clinicians evaluate and test patients for potential penicillin allergies.

21 Sep 2022

Scientists track origins of group 3 and group 4 medulloblastoma to the rhombic lip

Scientists at St. Jude Children's Research Hospital have discovered which cells give rise to certain high-risk groups of medulloblastoma.

21 Sep 2022

In-home device can monitor Parkinson's patient's movement and gait speed

Parkinson's disease is the fastest-growing neurodegenerative disease, now affecting more than 10 million people worldwide, yet clinicians still face huge challenges in tracking its severity and progression.

21 Sep 2022

Metabolic differences between early birds and night owls could help predict diabetes, heart disease risk

Are you an early bird or a night owl? Our activity patterns and sleep cycles could influence our risk of diseases, such as type 2 diabetes and heart disease.

21 Sep 2022

People experiencing bad dreams in middle age more likely to be diagnosed with dementia in future

People who experience frequent bad dreams in middle age are more likely to be diagnosed with dementia later in life, according to research at the University of Birmingham.

21 Sep 2022

Large clinical trial compares four drugs commonly used to treat type 2 diabetes

In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes, researchers found that insulin glargine and liraglutide performed the best of four medications approved by the U.S. Food and Drug Administration to maintain blood glucose levels in the recommended range.

21 Sep 2022

Mutation in newly discovered small protein linked to increase in Alzheimer's disease risk

A mutation in a newly discovered small protein is connected to a significant increase in the risk for Alzheimer's disease, expanding the known gene targets for the disease and presenting a new potential avenue for treatment, according to a new USC study.

21 Sep 2022

Public-private collaboration receives grant for research on microbiota-boosted cancer therapy

Health~Holland has awarded close to € 800,000 to a public-private partnership between UMC Utrecht, Artizan Biosciences, Inc. (USA) and MicroViable Therapeutics (Spain) to unravel how the intestinal microbiota can be exploited to boost cancer immunotherapy and limit therapy side-effects.

21 Sep 2022

Why fatigue from long COVID goes beyond simply feeling tired

In a recent study posted to the medRxiv* preprint server, researchers in the Netherlands examined the role of inflammatory genes, cytotoxic T-lymphocytes (CD8+ T cells), and pro-inflammatory cytokines in long-lasting severe fatigue experienced by a large number of coronavirus disease 2019 (COVID-19) patients.

21 Sep 2022

Medical Condition News

Mount Sinai researchers use unbiased AI-based method to study the causes of cognitive impairment

Cutting-edge technology uses MRI to diagnose patients with heart failure in record time

Medical cannabis use reduces sleep disturbances caused by PTSD

New genetically-targeted MND therapy could be a turning point for patient care

Global burden of type 1 diabetes likely to double by 2040, study predicts

Cardiovascular disease risk factors are largely the same for women and men, study shows

Artificial intelligence could help fast-track dementia diagnosis

Better physical fitness reduces frailty risk in patients with chronic lymphocytic leukemia

New guideline for the evaluation and testing of patients with penicillin allergies

Scientists track origins of group 3 and group 4 medulloblastoma to the rhombic lip

In-home device can monitor Parkinson's patient's movement and gait speed

Metabolic differences between early birds and night owls could help predict diabetes, heart disease risk

People experiencing bad dreams in middle age more likely to be diagnosed with dementia in future

Large clinical trial compares four drugs commonly used to treat type 2 diabetes

Mutation in newly discovered small protein linked to increase in Alzheimer's disease risk

Public-private collaboration receives grant for research on microbiota-boosted cancer therapy

Why fatigue from long COVID goes beyond simply feeling tired

Study: Life-threatening blood clots remain for at least 49 weeks after COVID-19

SARS-CoV-2 generates amyloid in cerebral spinal fluid

Combination of three existing drugs extends survival in mouse models of lethal brain cancer

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News